Ankylosing Spondylitis (AS)
Ankylosing Spondylitis is a form of axial spondyloarthritis characterized by chronic inflammation of the spine, sacroiliac joints, and entheses. Over time, vertebrae can fuse, limiting mobility and causing stooped posture. Early intervention slows damage and preserves quality of life.
Causes & Risk Factors
- Strong association with HLA-B27 gene
- Immune response to gut bacteria and environmental triggers
- Onset often before age 40, more common in men
- Family history of spondyloarthritis increases risk
Symptoms
- Chronic low back pain and stiffness lasting >3 months
- Pain improves with activity, worsens with rest (inflammatory pattern)
- Morning stiffness >30 minutes
- Limited spinal flexibility, reduced chest expansion
- Pain in heels, ribs, shoulders, or hips
- Eye inflammation (uveitis), fatigue, weight loss
Seek emergency care for vision changes, severe chest pain, or neurological symptoms.
Diagnosis
- History & exam focusing on inflammatory back pain criteria
- Imaging: X-rays revealing sacroiliitis or syndesmophytes; MRI detects early inflammation
- Labs: HLA-B27 testing, elevated CRP/ESR (not always present)
- Exclude mechanical back pain or other rheumatologic diseases
Treatment
Medications
- NSAIDs are first-line for pain and stiffness.
- Biologics: TNF inhibitors, IL-17 inhibitors for persistent disease.
- JAK inhibitors approved for refractory cases.
- Analgesics/muscle relaxants for symptom relief.
Physical Therapy & Exercise
- Daily stretching, posture training, and core strengthening.
- Swimming and yoga to maintain flexibility.
- Breathing exercises to preserve chest expansion.
Lifestyle
- Quit smoking; it worsens lung function and fusion risk.
- Ergonomic workstations and supportive mattresses.
- Heat therapy or warm showers in the morning.
Complications
- Spine fusion leading to decreased mobility
- Osteoporosis and fracture risk
- Cardiovascular disease and aortic valve issues
- Uveitis, inflammatory bowel disease, psoriasis
Research & Future Approaches
Studies focus on early detection via MRI biomarkers, gut microbiome modulation, and precision biologics tailored to immune signatures.
Experimental & Emerging Treatments
- JAK/TYK2 Inhibitors: Beyond approved JAK inhibitors, newer TYK2 agents are being evaluated for axial spondyloarthritis to deliver oral options with fewer side effects.
- Microbiome-Modifying Therapies: Trials investigate antibiotics, probiotics, and fecal microbiota transplant to rebalance gut bacteria implicated in AS inflammation.
- Cellular Therapies: Mesenchymal stem cell infusions are being explored for their potential to reduce cytokine levels and protect joints, though evidence is early.
- Vagus Nerve & Neuromodulation Devices: Experimental neuromodulation aims to calm systemic inflammation through the cholinergic anti-inflammatory pathway.
Track AS Progression with Diagnoza.care
Support Your Ankylosing Spondylitis Care – Capture pain scores, mobility drills, biologic injections, and ophthalmology visits, schedule physical therapy in the AI calendar, log side effects, and let the AI companion highlight stiffness trends to share with your rheumatologist.
Medical Disclaimer: Informational only. Coordinate care with your rheumatology team before making exercise or medication changes.
Sources: Spondylitis Association of America, American College of Rheumatology, National Institute of Arthritis and Musculoskeletal and Skin Diseases